-
Crizotinib Hydrochloride in Gastric Assembloids
2026-09-15
Crizotinib hydrochloride provides a practical ALK, c-Met, and ROS1 pathway probe for patient-derived gastric cancer assembloids. Combining target-engagement measurements with matched tumor–stroma models can reveal response shifts that are invisible in organoid-only screens.
-
Latrunculin B for Actin Dynamics Workflows
2026-09-15
Latrunculin B offers a cell-permeable, short-duration way to test how actin filament assembly shapes morphology, trafficking, and entry phenotypes. Its serum-sensitive activity makes it especially useful for timed perturbations, matched vehicle controls, and mechanistic experiments where a negative result can be as informative as a positive one.
-
Wnt agonist 1: Assay Logic for Wnt–GPX4 Studies
2026-09-14
Wnt agonist 1, also known as BML-284, provides a controlled way to study canonical Wnt signaling and β-catenin–TCF transcription. This article develops an evidence-aware assay framework linking pathway activation with differentiation, metabolism, and chemoresistance without overstating what current data prove.
-
Mubritinib (TAK 165): Beyond HER2
2026-09-14
Mubritinib (TAK 165) is best understood not simply as a historical HER2 inhibitor, but as a mechanistically useful perturbation of mitochondrial complex I and oxidative phosphorylation. This thought-leadership analysis connects its activity in chemotherapy-resistant AML and KSHV-positive PEL with translational study design, formulation, pharmacology, and evidence discipline. It also explains why pH-mediated absorption research provides a valuable framework without justifying direct extrapolation to Mubritinib.
-
SLC2A5 Fructose Metabolism in Primary CNS Lymphoma
2026-09-13
A 2026 Advanced Science study uses single-cell profiling to identify SLC2A5-mediated fructose metabolism as a metabolic vulnerability in primary central nervous system lymphoma. Its findings connect glucose-poor, hypoxic tumor microenvironments with lymphoma-cell adaptation, macrophage support, and T-cell dysfunction, while functional perturbations provide a rationale for spatial and mechanistic validation.
-
Alpha-Ketoglutarate Workflows for Metabolic Research
2026-09-12
Use alpha-ketoglutarate as a controlled metabolic perturbation, an enzyme substrate, and a mechanistic probe for tumor–immune interactions. This workflow translates PDHA1 succinylation findings into practical metabolite, signaling, and macrophage antigen-presentation assays while separating exploratory conditions from established evidence.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-09-12
The reference study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical tumor suppressor replacement in bladder cancer. Its preclinical results link bladder-restricted expression with cell-cycle suppression, DNA-damage signaling, apoptosis, and reduced orthotopic tumor growth, while also defining important questions for formulation and translational validation.
-
Carbapenemase Gene Transmission in Enterobacter cloacae
2026-09-11
Chen et al. combined gene localization, susceptibility testing, plasmid conjugation, mobile-element analysis, and ERIC-PCR to characterize carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study identifies plasmid-associated blaNDM-1 as a major transferable resistance determinant and shows how horizontal gene transfer and clonal dissemination can coexist in hospital surveillance.
-
Carboplatin Assay Design: From DNA Damage to Decisions
2026-09-11
Carboplatin is a platinum-based DNA synthesis inhibitor with broad utility in preclinical oncology research. This guide presents an evidence-aware framework for selecting models, integrating orthogonal endpoints, and translating systematic-review insights into more informative cancer research assays.
-
Polygodial: Turning TRPA1 Signals into Translation
2026-09-10
Polygodial offers translational researchers a practical chemical handle for probing TRPA1-dependent sensory signaling. This article connects acute channel activation with calcium/NFAT biology, epithelial inflammatory outputs, assay design, and the limits of moving from mechanistic evidence to translational interpretation.
-
JNK-IN-7: A Translational Lens on JNK Signaling
2026-09-10
JNK-IN-7 offers a precise way to interrogate JNK1, JNK2, and JNK3 in inflammation- and infection-associated apoptosis models. By connecting covalent target engagement with phase-specific Candida krusei biology, this article provides a strategic framework for translational MAPK research, pathway validation, and assay design.
-
HotStart™ Universal 2X Green qPCR Master Mix for HCC
2026-09-09
Discover how HotStart™ Universal 2X Green qPCR Master Mix can support targeted validation of AI-derived hepatocellular carcinoma biomarkers. This article connects consensus prognostic modeling with assay design, specificity controls, and reproducible gene expression quantification.
-
FOXN1 Reprogramming of Fibroblasts into TECs
2026-09-09
The 2024 Development study dissects how FOXN1 converts mouse embryonic fibroblasts into induced thymic epithelial cells, revealing distinct early and late transcriptional phases and mixed cortical and medullary lineage features. Its experiments show that proliferation, Notch inhibition, and thymocyte co-culture can improve specific aspects of programming, while MHC class II remains the principal difference from fetal thymic epithelium.
-
Aconitase Activity Colorimetric Assay Kit Guide
2026-09-08
Translate aconitase function into a practical readout for TCA-cycle integrity, oxidative damage, and immune-cell metabolic studies. This workflow shows how K2226 complements splicing, protein, and cytokine measurements without treating aconitase activity as a direct surrogate for metabolic flux.
-
SC 79 Akt Activator: Mechanism and Evidence
2026-09-08
SC 79 is a cytosolic Akt activator that binds the Akt pleckstrin homology domain and enhances Akt phosphorylation without changing total Akt protein. Product information and preclinical studies support its use in Akt signaling pathway research, neuroprotection in ischemic stroke models, and mechanistic cancer biology experiments.